The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan

Cancer Research

Volumn 57, Issue 9, 1997, Pages 1625-1629

  Seed, Michael Peter ^a   Brown, Joanne Rosalie ^a   Freemantle, Claire Nicole ^a   Papworth, Jonathan Leslie ^a   Colville Nash, Paul Richard ^a   Willis, Dean ^a   Somerville, Kevin William ^a   Asculai, Samuel ^b   Willoughby, Derek Albert ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b Hyal Pharmaceutical Corporation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; HYALURONIC ACID;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; TOPICAL DRUG ADMINISTRATION;

ADENOCARCINOMA; ADMINISTRATION, TOPICAL; ANIMALS; ANTIGENS, CD31; APOPTOSIS; CELL SURVIVAL; COLONIC NEOPLASMS; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; HYALURONIC ACID; MICE; MICE, INBRED BALB C; MITOSIS; NEOVASCULARIZATION, PATHOLOGIC; VEHICLES;

EID: 0031006644     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Alam, C. A. S., Seed, M. P., and Willoughby, D. A. Angiostasis and vascular regression in chronic granulomatous inflammation induced by diclofenac in combination with Hyaluronan. J. Pharm. Pharmacol., 47: 407-411, 1995.
2. Harper, D. A review of current clinical trials with HYAL CT-1101, HYAL AT-2101 and HYAL AV-2201. R. Soc. Med. Round Table Ser., 33: 60-63, 1994.
3. Rivers, J., McLean, D. I., and Maddin, S. A novel topical treatment for actinic keratosis. R. Soc. Med. Round Table Ser., 40: 122-124, 1995.
4. Koyama, H., Narisawa, T., Kodama, M., Ishikawa, K., Kusaka, H., Yamazaki, Y., and Koyama, K. Potent effects of the prostaglandin synthesis inhibitor indomethacin on the cellular immune response in gastrointestinal patients. J. Jpn. Soc. Cancer Ther., 24: 1027-1033, 1989.
5. Colville-Nash, P. R., and Seed, M. P. The current state of angiostatic therapy, with special reference to rheumatoid arthritis. Curr. Opin. Invest. Drugs, 2: 763-813, 1993.
6. Seed, M. P. Angiogenesis as a target for therapy: an update. Expert Opin. Invest. Drugs, 5: 1617-1637, 1996.
7. Simmons, D. L., Lu, X., Bradshaw, W. S., and Xie, W. The dilemma of two cyclo-oxygenases: identifying the roles of Cox-1 and Cox-2 in inflammation and apoptosis. In: J. R. Vane, J. Botting, and R. Botting (eds.), Improved Non-steroidal Anti-inflammatory Drugs: Cox-2 Enzyme Inhibitors, pp. 45-65. Lancaster, United Kingdom: Kluwer Academic Publishers 1996.
8. Russell, A. L. The use of HYAL AT-2101 and diclofenac in the treatment of osteoarthritis. R. Soc. Med. Round Table Ser., 36: 58-65, 1995.
9. Sioufi, A., Pommier, F., Boschett, F., Godbillon, J., Lavoignat, D., and Salliere, D. Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel. Biopharm. & Drug Dispos., 15: 441-449, 1994.
10. Brown, M. B., Bennett, F., Marriott, C., and Martin, G. P. Hyaluronan: a transdermal drug delivery system: an in vitro investigation. Progr. Rheumatol., 6: 59-63, 1996.
11. Seed, M. P., Alam, C. A. S., Brown, J., Freemantle, C. N., and Willoughby, D. A. The delivery of diclofenac to pathological tissues by hyaluronan (HYAL EX-0001). R. Soc. Med. Round Table Ser., 40: 74-81, 1995.
12. Seed, M. P., Freemantle, C., Alam, C. A. S., Colville-Nash, P. R., Gilroy, D., Brown, J., Papworth, J., Somerville, K., and Willoughby, D. A. Inhibition of colon-26 tumour growth and angiogenesis: findings on p.o. and topical NSAIDs in hyaluronan in vivo, and using Cox-1 and Cox-2 inhibitors in vitro. Prostaglandins Leukotrienes Essent. Fatty Acids, 55 (Suppl. 1): 180, 1996.
13. Andrade, S., Hart, I. R., and Piper, P. J. Inhibitors of nitric oxide synthase selectively reduce flow in tumour associated neovasculature. Br. J. Pharmacol., 107: 1092-1095, 1992.
14. Colville-Nash, P. R., Alam, C. A. S., Appleton, I., Brown, J. R., Seed, M. P., and Willoughby, D. A. The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. J. Pharmacol. Exp. Ther., 274: 1463-1472, 1995.
15. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 2: 149-153, 1995.
16. Battistini, B., Botting, R., and Bakhle, Y. S. Cox-1 and Cox-2: towards the development of more selective agents. Drug News & Perspect., 7: 501-512, 1994.
17. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells over expressing prostaglandin endoperoxide synthase-2. Cell, 8: 493-501, 1995.
18. Brown, J., and Fraser, J. R. E. Absorption of hyaluronan applied to the surface of the skin. R. Soc. Med. Round Table Ser., 40: 31-39, 1995.
19. Bartolazzi, A., Peach, R., Arufo, A., and Stamenkovic, I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med., 180: 53-66, 1994.